AGENDA - Specialized Session T2
June 17, 2020, 11am to 4pm ET: Part 1
June 18, 2020, 11am to 4pm ET: Part 2

"Innovation in Flow Cytometry, Mass Cytometry, and Imaging Cytometry to Solve Complex Method Development Issues in Drug Discovery/Development and Clinical Applications: What’s New for Bioanalytical Labs using Cytometry for Biomarkers, Immunogenicity, Cell Therapy and Cellular and Immuno-Oncology Assays?"

Learn from advanced case studies on Fluorescence-Based Flow Cytometry reduction in the complexity, increase in automation & sensitivity and capacity to detect rare populations. Learn the major advantages & challenges in using Mass Cytometry (CyTOF) & Imaging Cytometry vs traditional Flow Cytometry. How can your assay be improved by extending Flow Cytometry capabilities to high-throughput / high-content, single-cell assays, unmet antibody specificities in a single sample and without spillover between channels?

Cytometry Part 1: June 17, 2020 (EDT time listed)

11:00am-11:10am: Dr. Alessandra Vitaliti, Executive DirectorMolecular and Cellular Biomarker, Novartis
"Introduction of Cytometry Part 1"

New Insights in Automated Gating

Chair: Dr. Alessandra Vitaliti, Executive DirectorMolecular and Cellular Biomarker, Novartis
11:10am-11:30am: Dr. Michael Hedrick, Director Clinical Flow Cytometry, Bristol-Myers Squibb
"Autogating: A Solution to the Massive Data Generated by High Order Clinical Flow Assays"
11:30am-12:00pm: Mr. Alberto Hidalgo Robert, Scientific Researcher OMNI Biomarker Development, Genentech
"Implementation of Automated Gating Strategies for Quality Control and Analysis of Flow Cytometry Data"
12:00pm-12:20pm: Dr. Shabnam Tangri, Chief Scientific Officer, Navigate/Novartis
"High Dimensional Flow Cytometry in Immuno-Oncology"
12:20pm-12:50pm: Social Networking - Time to "Visit" Exhibitors and Posters
12:50pm-01:20pm: Dr. Michael Hedrick, Director Clinical Flow Cytometry, Bristol-Myers Squibb
Mr. Alberto Hidalgo Robert, Scientific Researcher OMNI Biomarker Development, Genentech
Dr. Shabnam Tangri, Chief Scientific Officer, Navigate/Novartis
Dr. Alessandra Vitaliti, Executive DirectorMolecular and Cellular Biomarker, Novartis
"Panel Discussion on Automated Gating"

Innovation in High Dimensional / High Parameter Flow Cytometry

Chair: Dr. Lindsay King, Assoc. Research Fellow BioMedicines Design, Pfizer
01:20pm-01:50pm: Dr. Sandra Nuti, Head Flow Cytometry Core Facility, Vaccines GlaxoSmithKline
"HP Flow Cytometry: Instrument Harmonization and Panel Design"
01:50pm-02:10pm: Dr. Vilma Decman, Director and Head Cellular Biomarkers, GlaxoSmithKline
"Recent Developments in Multi-parameter Flow Cytometry and Assay Development Strategies"
02:10pm-02:40pm: Ms. Megan McCausland, Translation R&D Scientist, Q2 Solutions
"Current Challenges in Performing ≥ 30 Color Flow Cytometry Experiments"
02:40pm-03:00pm: Dr. Richard Wnek, Scientific Director Translational Molecular Biomarkers, Merck
"Advanced Cytometric Biomarker Analysis in Oncology Clinical Development"
03:00pm-03:30pm: Social Networking - Time to "Visit" Exhibitors and Posters
03:30pm-04:00pm: Dr. Sandra Nuti, Head Flow Cytometry Core Facility, Vaccines GlaxoSmithKline
Dr. Vilma Decman, Director and Head Cellular Biomarkers, GlaxoSmithKline
Ms. Megan McCausland, Translation R&D Scientist, Q2 Solutions
Dr. Richard Wnek, Scientific Director Translational Molecular Biomarkers, Merck
Dr. Lindsay King, Assoc. Research Fellow BioMedicines Design, Pfizer
"Panel Discussion on Innovation in Cytometry"


Cytometry - Part 2: June 18, 2020 (EDT time listed)

11:00am-11:10am: Dr. Alessandra Vitaliti, Executive Director Molecular and Cellular Biomarker, Novartis
"Introduction of Cytometry Part 2"

Imaging Cytometry and Implementation of Complex Assays in Clinical Trials

Chair: Dr. Alessandra Vitaliti, Executive Director Molecular and Cellular Biomarker, Novartis
11:10am-11:30am: Dr. Alessandra Vitaliti, Executive DirectorMolecular and Cellular Biomarker, Novartis
"Image Cytometry: A New Powerful Tool That Combines Flow Cytometry and Microscopy Capabilities for Single Cell Analysis"
11:30am-11:50am: Dr. Priscila Teixeira, Scientific Leader Clinical Protein Biomarker Development, Roche
"High Parameter Flow Cytometry in the Clinic: Investigating Tumor Infiltrating Lymphocytes"
11:50am-12:10pm: Dr. Ulrike Sommer, Lab Head Cellular Biomarker, Novartis
"Recent Advancements in the Implementation of Fit for Purpose Flow Cytometry Assays in Clinical Trials"
12:10pm-12:40pm: Social Networking - Time to "Visit" Exhibitors and Posters
12:40pm-01:10pm: Dr. Alessandra Vitaliti, Executive DirectorMolecular and Cellular Biomarker, Novartis
Dr. Priscila Teixeira, Scientific Leader Clinical Protein Biomarker Development, Roche
Dr. Ulrike Sommer, Lab Head Cellular Biomarker, Novartis
"Panel Discussion on Imaging Cytometry & Complex Assays"

Advantages & Challenges in using Mass Cytometry (CyTOF) vs traditional Flow Cytometry

Chair: Dr. Lindsay King, Assoc. Research Fellow BioMedicines Design, Pfizer
01:10pm-01:30pm: Mr. Jose Estevam, Scientific Director and Center of Biomarker Innovation and Development, Takeda
"Advancements in Mass Cytometry: How to Ensure Robustness and Reproducibility When Using Mass Cytometry for Clinical Research"
01:30pm-01:50pm: Dr. Lindsay King, Assoc. Research Fellow BioMedicines Design, Pfizer
"Application of CyTOF to Derive Quantitative Biomeasures"
01:50pm-02:10pm: Mr. Gregory Hopkins, Sr. Assoc. Scientist Cellular Analytics Team, Bluebird Bio
A Comprehensive Strategy for Development and Validation of Immuno-oncology Focused Mass Cytometry Panels
02:10pm-02:40pm: Mr. Jose Estevam, Scientific Director and Center of Biomarker Innovation and Development, Takeda
Dr. Lindsay King, Assoc. Research Fellow BioMedicines Design, Pfizer
Mr. Gregory Hopkins, Sr. Assoc. Scientist Cellular Analytics Team, Bluebird Bio
"Panel Discussion on Mass Cytometry"
02:40pm-03:10pm: Social Networking - Time to "Visit" Exhibitors and Posters

2020 White Paper on Cytometry

03:10pm-03:30pm: Dr. Lindsay King, Assoc. Research Fellow BioMedicines Design, Pfizer
"Consensus & Recommendations on Cytometry"
03:30pm-04:00pm: Cytometry White Paper Working Experts Group
"Panel Discussion on Cytometry"




Final Agenda Agenda at a Glance